Inosine in neurodegenerative diseases: From the bench to the bedside

MS Basile, P Bramanti, E Mazzon - Molecules, 2022 - mdpi.com
Neurodegenerative diseases, such as Alzheimer′ s disease (AD), Parkinson's disease
(PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), currently represent …

[HTML][HTML] Inosine as a tool to understand and treat central nervous system disorders: a neglected actor?

FP Nascimento, SJ Macedo-Júnior… - Frontiers in …, 2021 - frontiersin.org
Since the 1970s, when ATP was identified as a co-transmitter in sympathetic and
parasympathetic nerves, it and its active metabolite adenosine have been considered …

[HTML][HTML] Inosine: a bioactive metabolite with multimodal actions in human diseases

IS Kim, EK Jo - Frontiers in Pharmacology, 2022 - frontiersin.org
The nucleoside inosine is an essential metabolite for purine biosynthesis and degradation; it
also acts as a bioactive molecule that regulates RNA editing, metabolic enzyme activity, and …

Protection by inosine in a cellular model of Parkinson's disease

S Cipriani, R Bakshi, MA Schwarzschild - Neuroscience, 2014 - Elsevier
Abstract Inosine (hypoxanthine 9-beta-d-ribofuranoside), a purine nucleoside with multiple
intracellular roles, also serves as an extracellular modulatory signal. On neurons, it can …

Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis

K Nicholson, J Chan, EA Macklin… - Annals of clinical …, 2018 - Wiley Online Library
Objective To test the safety, tolerability, and urate‐elevating capability of the urate precursor
inosine taken orally or by feeding tube in people with amyotrophic lateral sclerosis (ALS) …

Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions

FC Teixeira, JM Gutierres, MSP Soares… - …, 2020 - Springer
Rationale Inosine is a naturally occurring purine nucleoside formed by adenosine
breakdown. This nucleoside is reported to exert potent effects on memory and learning …

The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases

AJ López-Gambero, C Sanjuan, PJ Serrano-Castro… - Biomedicines, 2020 - mdpi.com
Inositols are sugar-like compounds that are widely distributed in nature and are a part of
membrane molecules, participating as second messengers in several cell-signaling …

Immunomodulatory and neuroprotective effects of inosine

G Haskó, MV Sitkovsky, C Szabo - Trends in pharmacological sciences, 2004 - cell.com
Adenosine has been considered as a potential immunomodulatory and neuroprotective
agent for 30 years. Inosine, a major degradation product of adenosine, was thought …

Targeting urate to reduce oxidative stress in Parkinson disease

GF Crotty, A Ascherio, MA Schwarzschild - Experimental neurology, 2017 - Elsevier
Oxidative stress has been implicated as a core contributor to the initiation and progression of
multiple neurological diseases. Genetic and environmental factors can produce oxidative …

One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan

H Iwaki, R Ando, N Miyaue, S Tada, T Tsujii… - Journal of the …, 2017 - Elsevier
Background Epidemiological studies have repeatedly reported that increased serum urate
level is associated with a slower progress of Parkinson's disease (PD). The urate precursor …